NYSE:CBT - Cabot Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $47.77 +0.78 (+1.66 %) (As of 11/22/2018 06:19 AM ET)Previous Close$46.99Today's Range$47.21 - $48.5952-Week Range$45.88 - $68.63Volume248,500 shsAverage Volume455,107 shsMarket Capitalization$2.89 billionP/E Ratio11.66Dividend Yield2.81%Beta1.5 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods. It also provides compounds of carbon black and rubber primarily for tire applications; and cesium formate, a drilling and completion fluid for use in high pressure and high temperature oil and gas well construction. In addition, the company offers specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; and fumed silica, fumed alumina, and dispersions for automotive, construction, microelectronics, batteries, and consumer products industries, as well as aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. Further, it provides activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; as a chemical carrier; and as a colorant or a decolorizing agent. The company sells its products primarily through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts. Receive CBT News and Ratings via Email Sign-up to receive the latest news and ratings for CBT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous chemical products Sub-IndustryCommodity Chemicals SectorBasic Materials Current SymbolNYSE:CBT Previous Symbol CUSIP12705510 Webwww.cabot-corp.com Phone617-345-0100 Debt Debt-to-Equity Ratio0.56 Current Ratio1.46 Quick Ratio0.92 Price-To-Earnings Trailing P/E Ratio11.66 Forward P/E Ratio10.41 P/E Growth0.97 Sales & Book Value Annual Sales$3.24 billion Price / Sales0.91 Cash Flow$6.6255 per share Price / Cash7.21 Book Value$20.78 per share Price / Book2.30 Profitability EPS (Most Recent Fiscal Year)$4.03 Net Income$-113,000,000.00 Net Margins-3.49% Return on Equity18.82% Return on Assets8.03% Miscellaneous Employees4,500 Outstanding Shares61,560,000Market Cap$2.89 billion OptionableOptionable Cabot (NYSE:CBT) Frequently Asked Questions What is Cabot's stock symbol? Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT." How often does Cabot pay dividends? What is the dividend yield for Cabot? Cabot announced a quarterly dividend on Friday, November 9th. Stockholders of record on Friday, November 30th will be given a dividend of $0.33 per share on Friday, December 14th. This represents a $1.32 annualized dividend and a dividend yield of 2.76%. The ex-dividend date of this dividend is Thursday, November 29th. View Cabot's Dividend History. How will Cabot's stock buyback program work? Cabot announced that its Board of Directors has initiated a share repurchase program on Monday, July 16th 2018, which permits the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 10.3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its stock is undervalued. How were Cabot's earnings last quarter? Cabot Corp (NYSE:CBT) posted its earnings results on Monday, November, 5th. The specialty chemicals company reported $1.00 EPS for the quarter, missing the consensus estimate of $1.09 by $0.09. The specialty chemicals company earned $850 million during the quarter, compared to analysts' expectations of $856.76 million. Cabot had a negative net margin of 3.49% and a positive return on equity of 18.82%. The firm's revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. View Cabot's Earnings History. When is Cabot's next earnings date? Cabot is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Cabot. What guidance has Cabot issued on next quarter's earnings? Cabot issued an update on its FY19 earnings guidance on Monday, November, 5th. The company provided earnings per share guidance of $4.35-4.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.70. Cabot also updated its FY 2019 guidance to $4.35-4.75 EPS. What price target have analysts set for CBT? 6 brokers have issued 12 month target prices for Cabot's stock. Their predictions range from $72.00 to $82.00. On average, they expect Cabot's stock price to reach $76.00 in the next year. This suggests a possible upside of 59.1% from the stock's current price. View Analyst Price Targets for Cabot. What is the consensus analysts' recommendation for Cabot? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cabot. Has Cabot been receiving favorable news coverage? Media stories about CBT stock have trended positive this week, InfoTrie reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cabot earned a media sentiment score of 2.2 on InfoTrie's scale. They also gave news stories about the specialty chemicals company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an effect on the company's share price in the immediate future. Who are some of Cabot's key competitors? Some companies that are related to Cabot include Versum Materials (VSM), Platform Specialty Products (PAH), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), HighCom Global Security (HCGS), GlyEco (GLYE), Ener-Core (ENCR) and Pure Bioscience (PURE). Who are Cabot's key executives? Cabot's management team includes the folowing people: Mr. Sean D. Keohane, Pres, CEO & Director (Age 51)Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 56)Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 48)Mr. Patrick M. Prevost, Advisor & Director (Age 63)Mr. Nicholas S. Cross, Former Exec. VP, Pres of Performance Chemicals segment & Pres of EMEA region (Age 57) Who are Cabot's major shareholders? Cabot's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.48%), Bank of New York Mellon Corp (5.45%), LSV Asset Management (4.03%), Fuller & Thaler Asset Management Inc. (3.27%), Earnest Partners LLC (2.47%) and Dimensional Fund Advisors LP (2.09%). Company insiders that own Cabot stock include Brian A Berube, Eduardo E Cordeiro, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot. Which institutional investors are selling Cabot stock? CBT stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, Morgan Stanley, FMR LLC, AXA, Scopus Asset Management L.P., Allianz Asset Management GmbH, Deutsche Bank AG and Dimensional Fund Advisors LP. Company insiders that have sold Cabot company stock in the last year include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Insider Buying and Selling for Cabot. Which institutional investors are buying Cabot stock? CBT stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Cabot Wellington LLC, Prudential Financial Inc., WINTON GROUP Ltd, Canada Pension Plan Investment Board, Man Group plc, Monarch Partners Asset Management LLC and James Investment Research Inc.. View Insider Buying and Selling for Cabot. How do I buy shares of Cabot? Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cabot's stock price today? One share of CBT stock can currently be purchased for approximately $47.77. How big of a company is Cabot? Cabot has a market capitalization of $2.89 billion and generates $3.24 billion in revenue each year. The specialty chemicals company earns $-113,000,000.00 in net income (profit) each year or $4.03 on an earnings per share basis. Cabot employs 4,500 workers across the globe. What is Cabot's official website? The official website for Cabot is http://www.cabot-corp.com. How can I contact Cabot? Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected] MarketBeat Community Rating for Cabot (NYSE CBT)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 309 (Vote Outperform)Underperform Votes: 348 (Vote Underperform)Total Votes: 657MarketBeat's community ratings are surveys of what our community members think about Cabot and other stocks. Vote "Outperform" if you believe CBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/22/2018 by MarketBeat.com StaffFeatured Article: What does the Dow Jones Industrial Average (DJIA) measure?